Sub-groups | Â | Analysis of HBV prevalence | Analysis of heterogeneity | Â | |||
---|---|---|---|---|---|---|---|
Variable | Category | No | Prevalence %(95%CI) | P value | I2% (95%CI) | P het | Model |
 | Kenya | 6 | 8.54 (5.09 to 12.76) Ref |  | 92.36 (86.11 to 95.79) | < 0.0001 | Random |
Country | Uganda | 9 | 8.454 (5.76 to 11.73) | 0.9637 | 97.28 (96.15 to 98.08) | < 0.0001 | Random |
 | Rwanda | 7 | 4.06 (3.80 to 4.34) | < 0.0001* | 85.39 (71.83 to 92.42) | < 0.0001 | Random |
 | Tanzania | 13 | 5.16 (4.24 to 6.17) | 0.0006* | 80.65 (67.84 to 88.35) | < 0.0001 | Random |
Year of Publication | 2011–2015 | 10 | 8.759 (6.09 to 11.85) Ref |  | 95.65 (93.65 to 97.2) | < 0.0001 | Random |
 | 2005–2010 | 8 | 6.95 (5.11 to 9.05) | 0.1208 | 87.4 (77.34 to 92.98) | < 0.0001 | Random |
 | 2016–2020 | 19 | 4.388 (3.901 to 4.903) | < 0.0001* | 96.17 (95.04 to 97.04) | < 0.0001 | Random |
Sampling Technique | Probability | 11 | 7.799 (5.182 to 10.897) |  | 98.45 (97.99 to 98.80) | < 0.0001 | Random |
 | Non-probability | 26 | 5.361 (4.567 to 6.215) | < 0.0001* | 96.91 (96.21 to 96.49) | < 0.0001 | Random |
Diagnostic Technique | ELISA | 14 | 5.214 (4.71 to 5.74) Ref |  | 90.48 (85.79 to 93.62) | < 0.0001 | Random |
 | RDT | 15 | 6.638 (4.997 to 8.493) | 0.0126* | 94.18 (91.88 to 95.83) | < 0.0001 | Random |
 | EIA | 4 | 6.127 (1.259 to 14.303) | 0.2349 | 99.62 (99.50 to 99.72) | < 0.0001 | Random |
 | Others | 4 | 3.924 (3.697 to 4.16) | 0.0622 | 22.55 (0.00 to 90.00) | 0.257 | Fixed |